The ERK1/2 pathway is documented to mediate tumor metastasis via regulating matrix metalloproteinases (MMPs) expression and activity and this plays a critical role in ECM degradation [37-39], a pivotal step during tumor metastasis [40, 41]. Here, MAPK3 is linked to neoplasm.